SRP14P3

Across TCGA pan-cancer cohorts, SRP14P3 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated SRP14P3 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher SRP14P3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SRP14P3 expression acts as an unfavorable survival marker, although some lineages such as STAD and LUAD show a favorable association.

UVM, STAD, and LUAD are the cancer types where SRP14P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	III,IV	0.557	0.853	.006	42	view →
STAD	OS	Quartile	All	0.552	0.330	.020	30	view →
LUAD	DFS	Tertile	IV	0.866	0.268	.023	20	view →
LIHC	DFS	Tertile	All	0.425	0.577	.008	18	view →
KIRP	OS	Tertile	IV	0.036	0.429	.006	18	view →
LAML	DFS	Tertile	All	0.698	0.300	.003	16	view →
BRCA	DFS	Median	IV	0.920	0.511	.011	14	view →
ACC	OS	Tertile	III,IV	0.244	0.670	.014	12	view →
OV	OS	Tertile	All	0.804	0.915	.012	10	view →
CESC	OS	Quartile	II,III,IV	0.893	0.698	.018	8	view →
UCEC	OS	Quartile	IV	0.547	0.843	.014	8	view →
SKCM	OS	Median	III,IV	0.611	0.298	.002	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

SRP14P3–UVM (OS)

Open the UVM breakdown →